About this item:

99 Views | 45 Downloads

Author Notes:

Kristen L. Nowak, PhD, MPH, Division of Renal Diseases and Hypertension, 12700 E 19th Ave C281, Aurora, CO 80045. Email: kristen.nowak@cuanschutz.edu

Research idea and study design: KLN, MC, BG; data acquisition: GB, KZA, WB, AC, PCH, DM, RP, VT, TS, AY; data analysis/interpretation: KLN, KM, KZA; statistical analysis: ZY; supervision or mentorship: MC. Each author contributed important intellectual content during manuscript drafting or revision, accepts personal accountability for the author’s own contributions, and agrees to ensure that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.

The authors declare that they have no relevant financial interests.

Subject:

Research Funding:

Dr Nowak is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), K01 DK103678, R03 DK118215, and the Baltimore PKD Research and Clinical Core Center Pilot and Feasibility Program (grant number P30DK090868).

The HALT studies were supported by NIDDK grants U01 DK062402, U01 DK062410, U01 DK082230, U01 DK062408, and U01 DK062401; the National Center for Research Resources General Clinical Research Centers (RR000039 to Emory University, RR000585 to the Mayo Clinic, RR000054 to Tufts Medical Center, RR000051 to the University of Colorado, RR023940 to the University of Kansas Medical Center, and RR001032 to Beth Israel Deaconess Medical Center); National Center for Advancing Translational Sciences Clinical and Translational Science Awards (RR025008 and TR000454 to Emory University, RR024150 and TR000135 to the Mayo Clinic, RR025752 and TR001064/UL1TR002544 to Tufts University, RR025780 and TR001082 to the University of Colorado, RR025758 and TR001102 to Beth Israel Deaconess Medical Center, RR033179 and TR000001 to the University of Kansas Medical Center, and RR024989 and TR000439 to Cleveland Clinic); by funding from the Zell Family Foundation (to the University of Colorado); and by a grant from the PKD Foundation. The funding agencies had no direct role in the conduct of the study; the collection, management, analyses, and interpretation of the data; or preparation or approval of the manuscript.

Keywords:

  • Body mass index
  • obesity
  • pain
  • polycystic kidney disease
  • weight loss

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies

Show all authors Show less authors

Tools:

Journal Title:

Kidney Medicine

Volume:

Volume 3, Number 4

Publisher:

, Pages 536-545.e1

Type of Work:

Article | Final Publisher PDF

Abstract:

Rationale & Objective: Pain is a frequent complication of autosomal dominant polycystic kidney disease (ADPKD) and includes back and abdominal pain. We hypothesized that in adults with early- and late-stage ADPKD, overweight and obesity are independently associated with greater self-reported back, abdominal, and radicular pain at baseline and that weight loss would be associated with decreased pain over a follow-up period. Study Design: Post hoc analysis of pooled data from 2 randomized trials. Setting & Participants: Participants in the HALT-PKD study A or B. 867 individuals were included in a cross-sectional analysis. 4,248 observations from 871 participants were included in a longitudinal analysis. Predictor: Overweight and obesity (cross-sectional); annual change in weight as a time-varying predictor (longitudinal). Outcome: Pain (Likert-scale responses; cross-sectional); annual change in pain (binary outcome of worsening pain or not worsening; longitudinal). Analytical Approach: Multivariable ordinal logistic regression (cross-sectional); generalized estimating equation analysis (longitudinal). Results: Participants were aged 42±10 years and baseline estimated glomerular filtration rate was 71±26 mL/min/1.73 m2. Back, abdominal, and radicular pain were reported more frequently in individuals with increasing body mass index category (all P < 0.05 for trend). After multivariable adjustment, obesity was associated with increased odds of greater back and radicular pain, but not abdominal pain. Associations remained similar after further adjustment for baseline height-adjusted kidney and liver volume (study A only, n = 457); back pain: OR, 1.88 (95% CI, 1.15-3.08); and radicular pain: OR, 2.92 (95% CI, 1.45-5.91). Longitudinally (median follow-up, 5 years), weight loss (annual decrease in weight ≥ 4%) was associated with decreased adjusted odds of worsening back pain (OR, 0.87 [95% CI, 0.76-0.99]) compared with the reference group (stable weight). Limitations: Post hoc, associative analysis. Conclusions: In early- and late-stage ADPKD, obesity was associated with greater back and radicular pain independent of total kidney/liver volume. Mild weight loss was associated with favorable effects on back pain.

Copyright information:

© 2021 The Authors

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/rdf).
Export to EndNote